HSP90AA1 and plasma cell myeloma: PU-H71 exhibits potent anti-myeloma activity in cell lines by inhibiting both the cytoplasmic and ER resident Hsp90 (Grp94) resulting in the activation of the UPR and caspase dependent apoptosis in myeloma cell lines [194] [195].